HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - P/B ratio
P/B ratio as of May 2024 : 0.1971
According to HTG Molecular Diagnostics
's latest financial reports the company has a price-to-book ratio of 0.1971.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
HTG Molecular Diagnostics - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.38 | -14.37% |
| 2021-12-31 | 3.94 | 151.63% |
| 2020-12-31 | 1.57 | -7.86% |
| 2019-12-31 | 1.70 | -50.59% |
| 2018-12-31 | 3.44 | -141.48% |
| 2017-12-31 | -8.30 | 193.26% |
| 2016-12-31 | -2.83 | -260.19% |
| 2015-12-31 | 1.77 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | 4.50 | 2,180.70% | 🇺🇸 USA |
 Affimed
AFMD | 1.26 | 540.62% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | 0.0048 | -97.58% | 🇺🇸 USA |